Cynata Therapeutics Ltd
ASX:CYP

Watchlist Manager
Cynata Therapeutics Ltd Logo
Cynata Therapeutics Ltd
ASX:CYP
Watchlist
Price: 0.305 AUD 5.17% Market Closed
Market Cap: 72.4m AUD

Intrinsic Value

The intrinsic value of one CYP stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.305 AUD, Cynata Therapeutics Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYP Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Cynata Therapeutics Ltd

Intrinsic Value History
Dive into the past to invest in the future

CYP looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CYP usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CYP?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CYP valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cynata Therapeutics Ltd.

Explain Valuation
Compare CYP to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CYP?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cynata Therapeutics Ltd

Current Assets 5.3m
Cash & Short-Term Investments 5.1m
Receivables 101.1k
Other Current Assets 194.6k
Non-Current Assets 1.8m
Intangibles 1.8m
Current Liabilities 1.2m
Accounts Payable 393.9k
Accrued Liabilities 822.3k
Efficiency

Free Cash Flow Analysis
Cynata Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cynata Therapeutics Ltd

Revenue
227.7k AUD
Operating Expenses
-9.6m AUD
Operating Income
-9.4m AUD
Other Expenses
-7.4k AUD
Net Income
-9.4m AUD
Fundamental Scores

CYP Profitability Score
Profitability Due Diligence

Cynata Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
hidden
Profitability
Score

Cynata Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CYP Solvency Score
Solvency Due Diligence

Cynata Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Cynata Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYP Price Targets Summary
Cynata Therapeutics Ltd

There are no price targets for CYP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cynata Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for CYP is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CYP stock?

The intrinsic value of one CYP stock under the Base Case scenario is hidden AUD.

Is CYP stock undervalued or overvalued?

Compared to the current market price of 0.305 AUD, Cynata Therapeutics Ltd is hidden .

Back to Top